CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024
01 Décembre 2023 - 12:00PM
Business Wire
Phreesia is very pleased to announce that the Centers for
Medicare and Medicaid Services (CMS) has included the Patient
Activation Measure Performance Measure (PAM-PM) in its Merit-Based
Incentive Payment System (MIPS), as well as in 15
specialty-specific measure sets and five MIPS Value Pathways
(MVPs), subsets of measures for specific conditions.
The Patient Activation Measure (PAM) measures a patient’s
knowledge, skills and confidence to self-manage their health.
Insignia Health, a wholly owned subsidiary of Phreesia, is the
measure steward of the PAM. Activated patients feel comfortable
advocating for themselves and asking for support from their care
team to manage their own health. But many patients who feel
discouraged and overwhelmed need more targeted support and
resources.
“Supporting patients in taking a more active role in their care
drives better outcomes, especially for patients who need it most,”
said Hilary Hatch, PhD, a clinical psychologist and Phreesia’s
Chief Clinical Officer. “It’s incredibly gratifying to see CMS
include the Patient Activation Measure Performance Measure in its
program as a high priority outcome measure. It’s a real testament
to the agency’s commitment to person-centered care and health
equity.”
In its 2024 Medicare Physician Fee Schedule published on Nov.
16, CMS said the PAM Performance Measure “ensures capture of the
patient voice and experience of care related to the patient's
understanding and confidence in the ability to manage their health
and be an active partner in their health care journey."
The PAM was developed nearly two decades ago by healthcare
services researcher Judith H. Hibbard, DrPH, at the University of
Oregon. Since then, a large body of research—more than 800
peer-reviewed research studies—demonstrates the unique value of
PAM. Evidence has shown that care teams can use a variety of
interventions tailored to patients’ needs to increase PAM scores,
improve outcomes, and lower costs. PAM is already used by hundreds
of healthcare organizations across the country, and beginning in
2024, MIPS-participating providers can report on gains in patient
activation as a new quality measure.
"The PAM plays a key role in helping us better understand our
patients, allocate our resources efficiently and get patients the
support they need," said Beth Wrobel, CEO of HealthLinc, a
federally qualified health center in northwest Indiana with 12
freestanding clinics. "We use the PAM in many ways, including to
assess patients' activation level and screen them for unmet social
needs so that we can deploy our limited resources to patients who
need them most."
"Activated patients are better able to self-manage their care
and adhere to treatment, and they have better outcomes,” said Tony
Nguyen, Systems Analyst & Implementation Lead at Congress
Orthopaedic Associates, an orthopedics group in California. “As a
practice that uses the Patient Activation Measure and participates
in MIPS, we're incredibly excited to see that PAM will be a MIPS
measure going forward. We believe it will improve the care we
provide, and in turn, the health and lives of our patients."
Dave White, a nationally known patient advocate who has worked
with organizations like the Patient Centered Outcomes Research
Initiative and the Kidney Health Initiative, emphasized the
transformative power of patient activation.
“Getting support to take a more active role in my care made a
difference and will for other people living with kidney disease and
a range of conditions as CMS includes the Patient Activation
Measure and screening for social drivers of health in MIPS,” said
White.
Support for the inclusion of the PAM in MIPS during the public
comment period came from groups as diverse as the American Society
of Nephrology (ASN), American College of Cardiology (ACC), American
Academy of Neurology (AAN), American Nurses Association (ANA),
National Alliance on Mental Illness (NAMI), the American Academy of
Orthopedic Surgeons (AAOS), National Kidney Foundation (NKF), the
American Diabetes Association (ADA), American Occupational Therapy
Association (AOTA) and AHIP.
About Phreesia
Phreesia is the trusted leader in patient activation, giving
providers, health plans, life sciences companies and other
organizations tools to help patients take a more active role in
their care. Founded in 2005, Phreesia enabled more than 120 million
patient visits in 2022–more than 1 in 10 visits across the
U.S.–scale that we believe allows us to make meaningful impact.
Offering patient-driven digital solutions for intake, outreach,
education and more, Phreesia enhances the patient experience,
drives efficiency and improves healthcare outcomes. To learn more,
visit www.phreesia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231201337654/en/
Media: Maureen McKinney mmckinney@phreesia.com
773-330-8908
Phreesia (NYSE:PHR)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Phreesia (NYSE:PHR)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024